Atabak Mokari, CFO: Corcept Therapeutics CORT Sell · Filed 06/17

Trade details

Type: Insider sale
Amount: $1,593,904.23
Shares · price: 19,483 sh · $81.81 a share
Held after: 16,132 sh
Stock: Corcept Therapeutics CORT
Person: Atabak MokariCFO
Trade date: 26/06/15
Filed: 26/06/17
Days to filing: 2 days

Sold 54.7% of holdings

Share of holding sold: 54.7%

Corcept Therapeutics trades, last 26 weeks

What else happened in Corcept Therapeutics around then

Filed or reported within 30 days of the trade day · 05/16~07/15

Atabak Mokari's recent trades

Atabak MokariCFO
Planned sale10b5-1 planCorcept Therapeutics
Planned sale10b5-1 plan
Corcept Therapeutics
CORT
$4.6M
40,000 sh
$4.6M
Filed 07/30
Traded 07/30
Atabak MokariCFO
Sell10b5-1 planCorcept Therapeutics
Sell10b5-1 plan
Corcept Therapeutics
CORT
$896.9K
11,081 sh
$896.9K
Filed 06/17
Traded 06/15
Atabak MokariCFO
Sell10b5-1 planCorcept Therapeutics
Sell10b5-1 plan
Corcept Therapeutics
CORT
$754.9K
9,434 sh
$754.9K
Filed 06/17
Traded 06/15
Atabak MokariCFO
Sell10b5-1 planCorcept Therapeutics
Sell10b5-1 plan
Corcept Therapeutics
CORT
$165
2 sh
$165
Filed 06/17
Traded 06/15
Atabak MokariCFO
Sell10b5-1 planCorcept Therapeutics
Sell10b5-1 plan
Corcept Therapeutics
CORT
$2.8M
40,000 sh
$2.8M
Filed 06/03
Traded 06/01